Skip to content

DNA X, Inc.

SONM

CIK 0001178697

← back to feed
Revenue (TTM)
$59.15M
−45.6% YoY Q1 May 2026
Net Income (TTM)
−$5.43M
+38.6% YoY Q1 May 2026
EPS Diluted (TTM)
$0.80
+77.7% YoY Q1 May 2026
Gross Margin
25.8%
Q1 May 2026
Operating Margin
-25.7%
Q1 May 2026
Net Margin
-9.2%
Q1 May 2026
Free Cash Flow (TTM)
−$17.76M
Q1 May 2026
Cash
$1.2M
Q1 May 2026
Total Debt
$1.32M
Q1 May 2026
Shares Outstanding
1.49M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings